Your immune system has a rapid-response unit. Natural Killer cells — NK cells — are its most aggressive and precise frontline soldiers. They identify abnormal cells — infected, cancerous, or senescent — and eliminate them without waiting for instruction from the adaptive immune system.
The problem: NK cell activity declines with age, chronic stress, inflammation, and poor metabolic health. The result is an immune system that is slower, less precise, and increasingly unable to clear the cellular threats that drive disease and accelerated aging.
NK cell therapy restores that capacity — and in doing so, reactivates one of the body’s most powerful tools for health protection and longevity.
Unlike T-cells, which require prior exposure to a pathogen to respond, NK cells operate on innate recognition — they identify abnormal cells immediately and act without delay. Their primary functions include:
• Identifying and destroying virally infected cells
• Eliminating senescent (‘zombie’) cells that drive inflammation and aging
• Clearing early-stage abnormal cell populations before they proliferate
• Regulating immune balance by coordinating with T-cells and dendritic cells
• Producing cytokines that direct the broader immune response
In a healthy, optimized immune system, NK cells run continuous surveillance. In a depleted system, threats accumulate unchecked.
• Adults experiencing age-related immune decline
• High-performers seeking to maintain immune resilience under chronic stress
• Individuals with frequent infections or slow recovery from illness
• Longevity-focused patients targeting senescent cell clearance
• Patients with chronic viral infections or post-viral syndromes (including long COVID)
• Autoimmune conditions driven by immune dysregulation
• Chronic fatigue syndromes with an immune component
• Inflammatory conditions where standard immune modulation has failed
• Patients seeking immune optimization alongside conventional oncology care
• Post-treatment immune restoration following chemotherapy or radiation
• Preventive immune surveillance for high-risk individuals
NK cell activity doesn’t exist in isolation. It is directly suppressed by the same root cause drivers that Chait addresses across every patient protocol: chronic inflammation, cortisol dysregulation, insulin resistance, and mitochondrial dysfunction.
This is why NK cell therapy at Chait’s practice is never a standalone infusion. It is delivered into a system that has been systematically prepared — inflammation reduced, hormones optimized, mitochondrial function restored — so the NK cells operate at peak capacity from the moment of administration.
Therapy Type Natural Killer (NK) Cell infusion
Administration Intravenous (IV) infusion
Source Allogeneic (donor-derived) expanded NK cells
Frequency Protocol-dependent — determined by assessment
Complementary Therapies Peptide immune support, Mycosurge, Lymphonest, hormonal optimization
NK cell therapy is an emerging immunotherapy and is not FDA-approved as a standard treatment for any specific condition outside of clinical trials. This content is for educational purposes only and does not constitute medical advice. Evan Chait is a licensed Physical Therapist and Acupuncturist, not a medical doctor (MD). Always consult a qualified, licensed healthcare professional before pursuing any immune cell therapy. Individual results may vary.
